Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ritika Kurian"'
Autor:
Sydney Stern, Dongdong Liang, Linhao Li, Ritika Kurian, Caitlin Lynch, Srilatha Sakamuru, Scott Heyward, Junran Zhang, Kafayat Ajoke Kareem, Young Wook Chun, Ruili Huang, Menghang Xia, Charles C. Hong, Fengtian Xue, Hongbing Wang
Publikováno v:
JCI Insight, Vol 7, Iss 12 (2022)
Cyclophosphamide (CPA) and doxorubicin (DOX) are key components of chemotherapy for triple-negative breast cancer (TNBC), although suboptimal outcomes are commonly associated with drug resistance and/or intolerable side effects. Through an approach c
Externí odkaz:
https://doaj.org/article/1a8ce16626d14dd984fe688ea0acc24d
Autor:
Sydney Stern, Dongdong Liang, Linhao Li, Ritika Kurian, Caitlin Lynch, Scott Heyward, Ajoke Kareem, Young Chun, Charles Hong, Fengtian Xue, Hongbing Wang
Publikováno v:
Journal of Clinical and Translational Science, Vol 5, Pp 98-98 (2021)
ABSTRACT IMPACT: Triple negative breast cancer (TNBC) affects 10-20% of women with breast cancer and is biologically more aggressive than other subtypes. The novel compound we have developed, DL7076, would give clinicians a vital strategy to improve
Externí odkaz:
https://doaj.org/article/eff90bbab36e49628ea8e6aba041e053
Publikováno v:
Cells, Vol 9, Iss 11, p 2520 (2020)
Non-Hodgkin’s lymphoma (NHL) is a malignant cancer originating in the lymphatic system with a 25–30% mortality rate. CHOP, consisting of cyclophosphamide (CPA), doxorubicin, vincristine, and prednisone, is a first-generation chemotherapy extensiv
Externí odkaz:
https://doaj.org/article/429d3b30522e4ba7844615164546f491
Publikováno v:
Drug Metabolism and Disposition. 50:1010-1018
Constitutive androstane receptor (CAR) (NR1I3), a xenobiotic receptor, has long been considered a master mediator of drug disposition and detoxification. Accumulating evidence indicates that CAR also participates in various physiologic and pathophysi
Autor:
Scott Heyward, Sydney Stern, Charles C. Hong, Dongdong Liang, Ajoke Kareem, Linhao Li, Caitlin Lynch, Ritika Kurian, Young Wook Chun, Fengtian Xue, Hongbing Wang
Publikováno v:
Journal of Clinical and Translational Science. 5:98-98
IMPACT: Triple negative breast cancer (TNBC) affects 10-20% of women with breast cancer and is biologically more aggressive than other subtypes. The novel compound we have developed, DL7076, would give clinicians a vital strategy to improve the commo